Portal Hypertension
Portal hypertension refers to a sustained increase in pressure within the portal venous system, which transports blood from the gastrointestinal tract and spleen to the liver. It most commonly develops as a consequence of chronic liver disease, particularly cirrhosis. When blood flow through the liver becomes restricted, pressure builds upstream, forcing blood to reroute through alternative pathways. These changes drive many of the most serious and recognisable complications of advanced liver disease.
What You Need to Know
Portal hypertension develops when resistance to blood flow through the portal venous system increases beyond the liver’s capacity to accommodate it. Under normal conditions, portal circulation functions as a low-pressure, high-volume system. In cirrhosis, fibrosis and regenerative nodules distort hepatic architecture, narrowing vascular channels and increasing intrahepatic resistance. As resistance rises, portal venous pressure increases and congestion develops in organs draining into the portal system, including the spleen and gastrointestinal tract.
To offset rising pressure, blood is diverted away from the liver through portosystemic collateral vessels that connect the portal and systemic circulations:
reduced forward flow through the liver
formation of collateral pathways to decompress the portal system
dilation of thin-walled vessels not designed for sustained high flow
While collateral formation partially relieves portal pressure, it comes at a cost. These vessels are structurally fragile and exposed to high shear stress, predisposing them to rupture and bleeding. At the same time, diversion of blood away from the liver further reduces hepatic perfusion, impairing detoxification and synthetic function and contributing to systemic complications.
Alcohol plays a central role in the development and progression of portal hypertension. Chronic alcohol exposure drives hepatocyte injury, inflammation, and progressive fibrosis, culminating in cirrhosis and fixed intrahepatic resistance. Alcohol also promotes splanchnic vasodilation, increasing portal blood inflow. The combination of increased resistance and increased inflow markedly amplifies portal pressure, accelerating the transition from compensated disease to clinically significant portal hypertension.
Beyond the Basics
Intrahepatic Resistance and Structural Distortion
The dominant mechanism underlying portal hypertension is increased resistance to blood flow within the liver itself. In cirrhosis, normal sinusoidal architecture is progressively replaced by fibrotic septa and regenerative nodules, disrupting the low-resistance vascular network that normally allows portal blood to pass freely through hepatic sinusoids. These fixed structural changes physically narrow and distort vascular channels, creating a persistent barrier to flow.
In addition to this static resistance, dynamic factors further increase intrahepatic pressure. Activated hepatic stellate cells contract in response to inflammatory and vasoactive signals, reducing sinusoidal diameter and increasing vascular tone. This combination of fixed architectural distortion and active vasoconstriction means resistance can fluctuate and worsen during physiological stress, infection, or ongoing injury, amplifying portal pressure beyond what structural change alone would predict.
Splanchnic Vasodilation and Increased Portal Inflow
Portal hypertension is not solely a consequence of impaired outflow through the liver; increased inflow into the portal system plays a critical amplifying role. Chronic liver disease is associated with excessive production of vasodilators, particularly nitric oxide, within the splanchnic circulation. This leads to widespread vasodilation of mesenteric vessels and increased blood pooling within the abdominal vascular bed.
As splanchnic vessels dilate, a larger volume of blood is delivered to the portal vein, raising portal venous inflow. Even as collateral pathways develop to decompress the system, this increased inflow often exceeds the liver’s reduced capacity to accommodate blood, sustaining or worsening portal hypertension. This explains why portal pressure may continue to rise despite extensive collateral formation.
Formation of Portosystemic Collaterals
As portal venous pressure increases, blood is diverted away from the liver through pre-existing portosystemic anastomoses. These collateral vessels enlarge progressively, forming alternative pathways between the portal and systemic circulations. Common sites include the oesophagus, stomach, rectum, and abdominal wall, reflecting regions where venous systems lie in close proximity.
While collateral formation partially decompresses the portal system, it fundamentally alters physiology. Blood bypasses hepatic metabolism and detoxification, increasing systemic exposure to substances normally cleared by the liver, such as ammonia and inflammatory mediators. The collateral vessels themselves are thin-walled and exposed to high flow and pressure, making them structurally unstable and prone to rupture, which underpins the risk and severity of variceal bleeding.
Effective Circulating Volume and Neurohormonal Activation
Despite total body fluid overload, portal hypertension produces a paradoxical reduction in effective circulating arterial volume. Blood pooling within the dilated splanchnic circulation and fluid sequestration into the peritoneal cavity reduce arterial filling and organ perfusion. The body interprets this as hypovolaemia despite expanded plasma volume.
In response, neurohormonal systems are activated, including the renin–angiotensin–aldosterone system, sympathetic nervous system, and antidiuretic hormone release. These responses promote sodium and water retention in an attempt to restore perfusion. Rather than correcting circulatory dysfunction, this maladaptive response worsens ascites, peripheral oedema, and dilutional hyponatraemia, reinforcing the haemodynamic instability of portal hypertension.
Alcohol’s Ongoing Contribution to Disease Progression
Alcohol plays a dual role in portal hypertension by increasing both resistance and inflow. Continued alcohol exposure sustains hepatocyte injury and inflammation, accelerating fibrotic progression and further narrowing intrahepatic vascular channels. This increases fixed resistance within the liver, raising baseline portal pressure.
At the same time, alcohol exacerbates splanchnic vasodilation through endothelial dysfunction and altered nitric oxide signalling, increasing portal venous inflow. In advanced disease, these effects synergise to markedly elevate portal pressure, increasing the likelihood of decompensation, variceal bleeding, and mortality. Portal hypertension therefore reflects not only accumulated structural damage but also ongoing physiological amplification driven by continued liver injury.
Clinical Connections
Portal hypertension underpins many of the hallmark complications seen in advanced liver disease and explains why patients may deteriorate abruptly even when liver enzymes appear stable. Many complications arise from altered haemodynamics rather than ongoing hepatocyte injury, which is why early recognition is clinically critical.
Key clinical manifestations directly linked to portal hypertension include:
Oesophageal and gastric varices, formed from high-pressure portosystemic collateral vessels, which carry a significant risk of sudden, life-threatening gastrointestinal bleeding
Splenomegaly and hypersplenism, resulting from venous congestion, leading to thrombocytopenia and increased bleeding risk even before overt coagulopathy develops
Ascites, driven by elevated portal pressure, renal sodium and water retention, and altered vascular permeability rather than simple fluid overload
Reduced effective circulating volume, contributing to renal dysfunction and increasing susceptibility to hepatorenal syndrome
Portosystemic shunting, which reduces hepatic detoxification and contributes to hepatic encephalopathy even in the absence of acute liver failure
In alcohol-related portal hypertension, these complications frequently coexist with malnutrition, impaired coagulation, sarcopenia, and recurrent infection, compounding clinical risk. Continued alcohol intake accelerates progression, increases the likelihood of variceal bleeding and encephalopathy, and significantly worsens prognosis.
Concept Check
What structural changes in cirrhosis increase intrahepatic vascular resistance?
Why does splanchnic vasodilation worsen portal hypertension?
How do portosystemic collaterals contribute to hepatic encephalopathy?
Why is effective circulating volume reduced despite fluid overload?
How does ongoing alcohol intake accelerate portal hypertension?